Brief: Adaptive Biotechnologies Corp - Issues $345 Million In 0% Convertible Senior Notes Due 2031 - SEC Filing
BRIEF-Adaptive Biotechnologies Corp - Issues $345 Million In 0% Convertible Senior Notes Due 2031 - SEC Filing June 22 (Reuters) - Adaptive Biotechnologies Corp ADPT.O:
ADAPTIVE BIOTECHNOLOGIES CORP - ISSUES $345 MILLION IN 0% CONVERTIBLE SENIOR NOTES DUE 2031 - SEC FILING
ADAPTIVE BIOTECHNOLOGIES CORP - NET PROCEEDS FROM OFFERING ABOUT $334.5 MILLION - SEC FILING
Source text: [ID:n0001193125-26-277516]
Further company coverage: ADPT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adaptive Biotechnologies
See all newsAdvisory: Alert incorrectly tagged to Adaptive Biotechnologies withdrawn
U.S. RESEARCH ROUNDUP-Cloudflare, Replimune, Walmart
U.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Adaptive Biotechnologies Corp reports results for the quarter ended June 30 - Earnings Summary
Adaptive Biotechnologies Q2 revenue rises 22%, beats estimates